266 related articles for article (PubMed ID: 29871924)
1. A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle.
Racz B; Varadi A; Kong J; Allikmets R; Pearson PG; Johnson G; Cioffi CL; Petrukhin K
J Biol Chem; 2018 Jul; 293(29):11574-11588. PubMed ID: 29871924
[TBL] [Abstract][Full Text] [Related]
2. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.
Dobri N; Qin Q; Kong J; Yamamoto K; Liu Z; Moiseyev G; Ma JX; Allikmets R; Sparrow JR; Petrukhin K
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):85-95. PubMed ID: 23211825
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and evaluation of nonretinoid retinol binding protein 4 antagonists for the potential treatment of atrophic age-related macular degeneration and Stargardt disease.
Cioffi CL; Dobri N; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Golden KC; Zhu L; Kitchen DB; Barnes KD; Racz B; Qin Q; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
J Med Chem; 2014 Sep; 57(18):7731-57. PubMed ID: 25210858
[TBL] [Abstract][Full Text] [Related]
4. Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease.
Lenis TL; Sarfare S; Jiang Z; Lloyd MB; Bok D; Radu RA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3987-3992. PubMed ID: 28348233
[TBL] [Abstract][Full Text] [Related]
5. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases.
Radu RA; Han Y; Bui TV; Nusinowitz S; Bok D; Lichter J; Widder K; Travis GH; Mata NL
Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4393-401. PubMed ID: 16303925
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetics and pharmacodynamics of the advanced Retinol-Binding Protein 4 antagonist in dog and cynomolgus monkey.
Racz B; Varadi A; Pearson PG; Petrukhin K
PLoS One; 2020; 15(1):e0228291. PubMed ID: 31978148
[TBL] [Abstract][Full Text] [Related]
7. Expression of ABCA4 in the retinal pigment epithelium and its implications for Stargardt macular degeneration.
Lenis TL; Hu J; Ng SY; Jiang Z; Sarfare S; Lloyd MB; Esposito NJ; Samuel W; Jaworski C; Bok D; Finnemann SC; Radeke MJ; Redmond TM; Travis GH; Radu RA
Proc Natl Acad Sci U S A; 2018 Nov; 115(47):E11120-E11127. PubMed ID: 30397118
[TBL] [Abstract][Full Text] [Related]
8. Bicyclic [3.3.0]-Octahydrocyclopenta[c]pyrrolo Antagonists of Retinol Binding Protein 4: Potential Treatment of Atrophic Age-Related Macular Degeneration and Stargardt Disease.
Cioffi CL; Racz B; Freeman EE; Conlon MP; Chen P; Stafford DG; Schwarz DM; Zhu L; Kitchen DB; Barnes KD; Dobri N; Michelotti E; Cywin CL; Martin WH; Pearson PG; Johnson G; Petrukhin K
J Med Chem; 2015 Aug; 58(15):5863-88. PubMed ID: 26181715
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.
Cioffi CL; Muthuraman P; Raja A; Varadi A; Racz B; Petrukhin K
J Med Chem; 2020 Oct; 63(19):11054-11084. PubMed ID: 32878437
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibition of lipofuscin accumulation in the retina as a therapeutic strategy for dry AMD treatment.
Petrukhin K
Drug Discov Today Ther Strateg; 2013; 10(1):e11-e20. PubMed ID: 25152755
[TBL] [Abstract][Full Text] [Related]
11. Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration.
Du M; Phelps E; Balangue MJ; Dockins A; Moiseyev G; Shin Y; Kane S; Otalora L; Ma JX; Farjo R; Farjo KM
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4375–4383. PubMed ID: 28813718
[TBL] [Abstract][Full Text] [Related]
12. The novel visual cycle inhibitor (±)-RPE65-61 protects retinal photoreceptors from light-induced degeneration.
Wang Y; Ma X; Muthuraman P; Raja A; Jayaraman A; Petrukhin K; Cioffi CL; Ma JX; Moiseyev G
PLoS One; 2022; 17(10):e0269437. PubMed ID: 36227868
[TBL] [Abstract][Full Text] [Related]
13. Dual
Dyka FM; Molday LL; Chiodo VA; Molday RS; Hauswirth WW
Hum Gene Ther; 2019 Nov; 30(11):1361-1370. PubMed ID: 31418294
[TBL] [Abstract][Full Text] [Related]
14. Evidence of complement dysregulation in outer retina of Stargardt disease donor eyes.
Hu J; Pauer GJ; Hagstrom SA; Bok D; DeBenedictis MJ; Bonilha VL; Hollyfield JG; Radu RA
Redox Biol; 2020 Oct; 37():101787. PubMed ID: 33214125
[TBL] [Abstract][Full Text] [Related]
15. Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development.
Kim N; Priefer R
Eur J Med Chem; 2021 Dec; 226():113856. PubMed ID: 34547506
[TBL] [Abstract][Full Text] [Related]
16. Products of the visual cycle are detected in mice lacking retinol binding protein 4, the only known vitamin A carrier in plasma.
Montenegro D; Zhao J; Kim HJ; Shmarakov IO; Blaner WS; Sparrow JR
J Biol Chem; 2022 Dec; 298(12):102722. PubMed ID: 36410431
[TBL] [Abstract][Full Text] [Related]
17. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease.
Wu Y; Fishkin NE; Pande A; Pande J; Sparrow JR
J Biol Chem; 2009 Jul; 284(30):20155-66. PubMed ID: 19478335
[TBL] [Abstract][Full Text] [Related]
18. A vicious cycle of bisretinoid formation and oxidation relevant to recessive Stargardt disease.
Zhao J; Kim HJ; Ueda K; Zhang K; Montenegro D; Dunaief JL; Sparrow JR
J Biol Chem; 2021; 296():100259. PubMed ID: 33837742
[TBL] [Abstract][Full Text] [Related]
19. Complement system dysregulation and inflammation in the retinal pigment epithelium of a mouse model for Stargardt macular degeneration.
Radu RA; Hu J; Yuan Q; Welch DL; Makshanoff J; Lloyd M; McMullen S; Travis GH; Bok D
J Biol Chem; 2011 May; 286(21):18593-601. PubMed ID: 21464132
[TBL] [Abstract][Full Text] [Related]
20. Bisretinoid-mediated complement activation on retinal pigment epithelial cells is dependent on complement factor H haplotype.
Radu RA; Hu J; Jiang Z; Bok D
J Biol Chem; 2014 Mar; 289(13):9113-20. PubMed ID: 24550392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
